Prothena Corp Public Ltd Co (PRTA) income statement
PRTANasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 5, 2026Score 12/3021% below fair value
$8.22−0.18 (-2.14%)
Close on Nov 20, 2026Market cap $421.99MP/E –Yield –
Prothena Corp Public Ltd Co financial ratios
See a number that looks wrong?